Clinical Trials Logo

Left Atrial Appendage Closure clinical trials

View clinical trials related to Left Atrial Appendage Closure.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06348394 Active, not recruiting - Clinical trials for Left Atrial Appendage Closure

Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion

ICETEE
Start date: December 14, 2023
Phase: N/A
Study type: Interventional

This single-center, prospective, randomized study will evaluate the safety and feasibility of Intracardiac echocardiography (ICE)-guided Left atrial appendage closure (LAAC) when compared to the traditional Transesophageal echocardiography (TEE) approach.

NCT ID: NCT03399851 Active, not recruiting - Clinical trials for Left Atrial Appendage Closure

Comparison of Amplatzer Amulet and Watchman Device in Patients Undergoing Left Atrial Appendage Closure. (SWISS-APERO)

SWISS-APERO
Start date: June 19, 2018
Phase: N/A
Study type: Interventional

Left atrial appendage closure (LAAC) is an emerging therapeutic option in non-valvular atrial fibrillation (NVAF) patients with high thromboembolic and bleeding risks. In Europe the devices most frequently utilized for LAAC are Amplatzer Amulet (St. Jude Medical-Abbott) and Watchman (Boston Scientific) system. However there are currently no randomized controlled trials assessing the degree of LAA closure between the two devices. The main purpose of this trial is to evaluate the feasibility and the efficacy of the devices in terms of LAA complete occlusion with a non-invasive imaging technique such as cardiac computed tomography angiography (CCTA).